nitrites has been researched along with Multiple Sclerosis, Chronic Progressive in 5 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Multiple Sclerosis, Chronic Progressive: A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Within IFNbeta-1a-treated patients with primary progressive multiple sclerosis, median UNCR values were significantly higher in clinically stable (no Expanded Disability Status Scale change) compared with progressive patients (p = 0." | 2.75 | Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis. ( Giovannoni, G; Leary, SM; Miller, DH; Petzold, A; Rejdak, K; Thompson, AJ, 2010) |
| "Patients with DD, AIDS and RA had significantly elevated urinary nitrate plus nitrite (nit : creat." | 1.30 | Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease. ( Elliot, M; Feldmann, M; Giovannoni, G; Heales, SJ; Land, JM; Miller, DH; Miller, RF; O'Riordan, J; Silver, NC; Thompson, EJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rejdak, K | 1 |
| Leary, SM | 1 |
| Petzold, A | 1 |
| Thompson, AJ | 1 |
| Miller, DH | 2 |
| Giovannoni, G | 2 |
| Ramsaransing, GS | 1 |
| Teelken, A | 1 |
| Arutjunyan, AV | 1 |
| De Keyser, J | 1 |
| Silver, NC | 1 |
| O'Riordan, J | 1 |
| Miller, RF | 1 |
| Heales, SJ | 1 |
| Land, JM | 1 |
| Elliot, M | 1 |
| Feldmann, M | 1 |
| Thompson, EJ | 1 |
| Peltola, J | 1 |
| Ukkonen, M | 1 |
| Moilanen, E | 1 |
| Elovaara, I | 1 |
| Yuceyar, N | 1 |
| Taşkiran, D | 1 |
| Sağduyu, A | 1 |
1 trial available for nitrites and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis.
Topics: Adult; Biomarkers; Chromatography, High Pressure Liquid; Colorimetry; Creatinine; Disability Evaluat | 2010 |
4 other studies available for nitrites and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course.
Topics: Adult; Axons; Female; Humans; Interleukin-12; Leukocytes; Male; Middle Aged; Multiple Sclerosis; Mul | 2004 |
Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Arthritis, Rheumatoid; CD4 Lymphocyte Count; Creati | 1999 |
Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy.
Topics: Adult; Atrophy; Brain; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; N | 2001 |
Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
Topics: Adolescent; Adult; Biomarkers; Brain; Case-Control Studies; Female; Humans; Magnetic Resonance Imagi | 2001 |